Search the Newsreel

Allogene rises as FDA offers Fast Track, RMAT tags to cell therapy

Shares of Allogene Therapeutics (ALLO [https://seekingalpha.com/symbol/ALLO]) rose on Wednesday after the U.S. Food and Drug Administration awarded the Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations for the company’s cell therapy candidate cema-cel. Also known as cemacabtagene ansegedleucel, the allogeneic CAR T product …

Allogene Therapeutics, Inc. Receives FDA Regenerative Medicine Advanced Therapy And Fast Track Designations For Cemacabtagene Ansegedleucel As First-Line Consolidation Therapy For Large B-Cell Lymphoma

Allogene Therapeutics has received both Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations from the FDA for its investigational CAR T product, cemacabtagene ansegedleucel (cema-cel). These designations are for cema-cel as a first-line consolidation therapy for adult patients with high-risk large B-cell lymphoma …

Allogene Therapeutics stock rises on FDA regulatory designations

Allogene Therapeutics Inc. (NASDAQ:ALLO) shares increased after the FDA granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations to its experimental therapy cema-cel. These designations are for treating adult patients with large B-cell lymphoma (LBCL) who test positive for minimal residual disease (MRD) …

Allogene Reports No Minimal Residual Disease in 7 of 12 Cema-Cel Patients

Allogene Therapeutics announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations to its investigational allogeneic CAR T therapy cemacabtagene ansegedleucel (cema-cel). These designations are based on interim data from the pivotal ALPHA3 trial, where 58.3% of cema-cel-treated …

Insider Sellers Might Regret Selling Allogene Therapeutics Shares at a Lower Price Than Current Market Value

Insiders at Allogene Therapeutics sold US$603k worth of shares over the past year at an average price of US$1.85, which is lower than the current share price. This suggests that these sellers might now regret their decision given the stock's recent price movements, despite …

Bisalloy Steel (ASX:BIS): Can Defence Demand Offset Softer Mining Conditions?

Ascent Industries Co (ACNT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Ascent Industries Co (ACNT), noting its current valuation score of 8.28, which ranks it 52nd out of 127 in the Metals & Mining industry. The company's current P/E ratio is 144.44, indicating it is significantly above its …

Guggenheim Active Allocation Fund Revenue Breakdown – NYSE:GUG

This article provides a brief overview of the Guggenheim Active Allocation Fund (GUG) on the New York Stock Exchange. It focuses on offering access to financial statements, statistics, dividends, earnings, and segment information, indicating that detailed revenue breakdown content is available on the TradingView …

Allogene Therapeutics Inc (ALLO) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Allogene Therapeutics Inc (ALLO)'s financial health, noting its current financial score of 5.10 and a ranking of 377 out of 385 in the Biotechnology & Medical Research industry, indicating a weak financial status and low operating efficiency. Key …

How (BCAT) Movements Inform Risk Allocation Models

This article analyzes Blackrock Capital Allocation Term Trust Of Beneficial Interest (NASDAQ: BCAT) using AI models to inform risk allocation. It highlights weak near-term sentiment but strong long-term prospects, detailing an exceptional 15.5:1 risk-reward setup targeting a 4.0% gain versus 0.3% risk. Three distinct …

BlackRock ESG Capital Allocation Term Trust Revenue Breakdown – BOATS:ECAT

This article provides a revenue breakdown for the BlackRock ESG Capital Allocation Term Trust (BOATS:ECAT). It highlights various financial aspects and market data available through TradingView, including fundamental statistics and segment performance. The content focuses on financial analysis tools rather than a detailed news …

Indian Metals & Ferro Alloys schedules Q1 FY27 earnings call

Ascent Industries Co (ACNT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Ascent Industries Co (ACNT), detailing its volatility, financial risk, and investment risk. ACNT has a current risk assessment score of 5.99, ranking 35 out of 127 in the Metals & Mining industry, and a beta of 0.55, …

Allot Ltd (ALLT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Allot Ltd (ALLT), detailing its volatility, financial risk, and investment risk. It highlights the company's beta value of 1.48, indicating higher sensitivity to market movements compared to the S&P 500. The assessment also includes various metrics such …

Ascent Industries Co. Revenue Breakdown – NASDAQ:ACNT

Ascent Industries Co (ACNT) Income Statement

This article provides the quarterly and annual income statements for Ascent Industries Co (ACNT), offering detailed financial data such as total revenue, cost of revenue, operating expenses, and net income stretching back to FY2012Q1. It allows users to analyze the company's financial performance and …

BlackRock (ACNT) discloses 161,979 Ascent Industries shares in amended ownership filing

BlackRock, Inc. has filed an amended ownership report (SCHEDULE 13G/A) for ASCENT INDUSTRIES CO. (ACNT), revealing beneficial ownership of 161,979 shares as of June 30, 2026. This represents 1.8% of the outstanding common stock, placing BlackRock below the 5% large-holder threshold. BlackRock reports sole …

Allot Ltd Q2 Results: Unaudited figures to drop before Aug 12 call

Allot Ltd. announced it will release its unaudited second-quarter 2026 results and host a conference call on August 12, 2026, at 8:30 AM ET. Financial statements will be published prior to the call, allowing investors to review key metrics. The company provides specific dial-in …

Allogene Therapeutics, Inc. Stock 12‑Month Price Target Cut to $8.75, Implies 381% Upside

Allogene Therapeutics, Inc.'s average 12-month stock price target has been lowered to $8.75 from $9 by 8 analysts, with forecasts ranging from $4 to $14 per share. This new target suggests a potential upside of approximately 381% based on the July 23 closing price. …

REalloys Inc. Revenue Breakdown – NASDAQ:ALOY

REalloys Inc. (NASDAQ: ALOY) reported its revenue breakdown, showing the majority of its last year's revenue of $2.40 million USD came from its Subscriptions segment, totaling $2.35 million USD. The United States was the largest geographical contributor, accounting for $2.43 million USD. This indicates …

Allogene Therapeutics Inc (ALLO) Cash Flow

This article provides a detailed cash flow statement for Allogene Therapeutics Inc (ALLO) on a quarterly and annual basis. It breaks down operating, investing, and financing cash flows, including specific line items such as net income from continuing operations, capital expenditures, and changes in …

Allot's second-quarter results arrive before an Aug. 12 webcast

Allot (NASDAQ/TASE: ALLT) announced it will release its unaudited second quarter 2026 financial results and host a conference call on Wednesday, August 12, 2026, at 8:30 AM ET. The financial results will be published before the call, and a live webcast will be available …

Allot to Release Second Quarter 2026 Results and Host Conference Call on August 12, 2026

Allot Ltd. announced it will host a conference call on August 12, 2026, to discuss its second-quarter 2026 financial results. The company, a provider of Security-as-a-Service and network intelligence solutions, will publish its unaudited results before the call. Investors can access the live webcast …

Ascent Industries Co (ACNT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Ascent Industries Co (ACNT) focusing on its dividend history and stock splits. It notes that the company has distributed $0.00 in dividends over the past five years and contains no historical dividend data. The page also presents current …

Allot Ltd (ALLT) Income Statement

This article provides a detailed quarterly income statement for Allot Ltd (ALLT), spanning several fiscal years. It includes key financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and basic and diluted earnings per share. The document also …

BlackRock Capital Allocation Term Trust Revenue Breakdown – NYSE:BCAT

This article provides details on the BlackRock Capital Allocation Term Trust (NYSE: BCAT), focusing on its revenue breakdown and financial overview. It lists various sections available for financial analysis, such as statements, statistics, dividends, earnings, and segments. The content also highlights the range of …

Allogene Therapeutics Inc (ALLO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Allogene Therapeutics Inc (ALLO)'s dividend history and stock splits. It states that the company has distributed $0.00 in dividends over the past five years and currently has no dividend data available. The content primarily focuses on the company's …

Allot Ltd. (ALLT) Gains 2.4% as Stock Approaches Key Resistance Zone - Dealer Positioning

Ascent Industries Co (ACNT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ascent Industries Co (ACNT), detailing its current price momentum score, support and resistance levels, and signals from various technical indicators and moving averages. While the stock is trading between resistance at $16.13 and support at $13.93, making …

ACNT|Ascent Industries Co|Price:15.125|Chg%:-0.045

The article provides a detailed financial overview of Ascent Industries Co (ACNT), including its stock price, market capitalization, P/E ratio, and upcoming earnings date. It presents comprehensive quarterly and annual financial statements, highlighting key indicators like EPS, Revenue, Net Profit, Net Margin, Gross Margin, …

Allogene Therapeutics, Inc. Revenue Breakdown – NASDAQ:ALLO

The article provides a revenue breakdown for Allogene Therapeutics, Inc. (NASDAQ: ALLO) as listed on TradingView. It indicates that the market is currently closed with no trades. The content primarily outlines the financial overview, statements, statistics, dividends, earnings, and market data sources for the …

PT Allo Bank Indonesia Tbk Revenue Breakdown – IDX:BBHI

Allot Ltd (ALLT) Institutional Confidence

Allot Ltd (ALLT) has an institutional shareholding score of 7.00, placing it 139th out of 485 companies in the Software & IT Services industry. The latest institutional shareholding proportion is 73.46%, which is a 7.21% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, …

ALLT|Allot Ltd|Price:7.645|Chg%:+0.175

Allot Ltd (ALLT) is an Israel-based company specializing in software solutions for the communication sector, providing security and network intelligence to mobile, fixed, and cloud service providers, as well as enterprises. The company's solutions include mobile security, DDoS protection, IoT security, and traffic control. …

Saba Capital sells 40,830 BlackRock ESG Capital Allocation Term Trust shares for $617,757.9

Saba Capital Management sold 40,830 shares of BlackRock ESG Capital Allocation Term Trust (NYSE:BBEZ) on July 23 for $15.13 per share, totaling $617,757.9. This transaction reduced Saba Capital's indirect stake to 16,651,985 shares, maintaining its status as a 10% owner. The sale was reported …

Ascent Industries Co (ACNT) Institutional Confidence

Ascent Industries Co (ACNT) has an institutional shareholding score of 5.00, placing it 48th out of 127 in the Metals & Mining industry. The current institutional shareholding proportion is 62.27%, which is a 12.22% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding …